menu
    • menu

    Company profile for Aphaia Pharma

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-12-22

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    HTL Biotechnology is a French biotech & a global leader in the responsible development & production of pharma-grade biopolymers.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Aphaia Pharma is a clinical-stage biopharmaceutical company harnessing proprietary precision-targeted drug formulations to restore endogenous hormone release from nutrient-sensing cells in the GI tract to treat and prevent metabolic disorders such as obesity and associated diseases. Aphaia’s lead candidate, APH-012, a glucose formulation, has been shown to safely restore endogenous hormone release in individuals with obesity...
    Aphaia Pharma is a clinical-stage biopharmaceutical company harnessing proprietary precision-targeted drug formulations to restore endogenous hormone release from nutrient-sensing cells in the GI tract to treat and prevent metabolic disorders such as obesity and associated diseases. Aphaia’s lead candidate, APH-012, a glucose formulation, has been shown to safely restore endogenous hormone release in individuals with obesity. APH-012 is now being evaluated in a Phase 2 trial in the U.S.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Aphaia PharmaSwitzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Bahnhofstrasse 28 CH-6300 Zug
    Telephone
    Telephone
    +41 41 784 96 33
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://aphaiapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/aphaia-pharma/about/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Aphaia Releases Phase 1 & 2 Clinical Data For Oral Formulation
    Aphaia Releases Phase 1 & 2 Clinical Data For Oral Formulation

    23 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/23/3154683/0/en/Aphaia-Pharma-Publishes-Phase-1-and-2-Clinical-Data-of-Oral-Formulation-in-Patients-with-Obesity-and-Prediabetes.html

    GLOBENEWSWIRE
    23 Sep 2025
    Share Share
    Aphaia Pharma Begins Phase 2 Oral Obesity Drug Trial
    Aphaia Pharma Begins Phase 2 Oral Obesity Drug Trial

    09 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/09/3146894/0/en/Aphaia-Pharma-Initiates-Second-Phase-2-Trial-of-Oral-Candidate-in-Obesity.html

    GLOBENEWSWIRE
    09 Sep 2025
    Share Share
    Aphaia Pharma to Participate in Panel Discussion at SXSW 2025
    Aphaia Pharma to Participate in Panel Discussion at SXSW 2025

    20 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/20/3029641/0/en/Aphaia-Pharma-to-Participate-in-Panel-Discussion-at-SXSW-2025.html

    GLOBENEWSWIRE
    20 Feb 2025
    Share Share
    Aphaia Pharma Joins BioPharma Obesity Forum Panel in San Francisco
    Aphaia Pharma Joins BioPharma Obesity Forum Panel in San Francisco

    19 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com//news-release/2024/12/19/2999869/0/en/Aphaia-Pharma-to-Participate-in-Panel-Discussion-at-the-1st-Annual-BioPharma-Obesity-Innovation-Forum-in-San-Francisco.html

    GLOBENEWSWIRE
    19 Dec 2024
    Share Share
    Aphaia Pharma to Join Panel at Obesity & Metabolic Innovation Forum
    Aphaia Pharma to Join Panel at Obesity & Metabolic Innovation Forum

    25 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/25/2986648/0/en/Aphaia-Pharma-to-Participate-in-a-Panel-Discussion-at-the-1st-Annual-Obesity-Metabolic-Innovation-Forum.html

    GLOBENEWSWIRE
    25 Nov 2024
    Share Share
    5 Obesity Readouts to Watch in the Second Half of 2024
    5 Obesity Readouts to Watch in the Second Half of 2024

    09 Aug 2024

    // BIOSPACE

    https://www.biospace.com/drug-development/5-obesity-readouts-to-watch-in-the-second-half-of-2024

    BIOSPACE
    09 Aug 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search